4:33 PM
 | 
Apr 25, 2017
 |  BC Extra  |  Company News

Management tracks

Eye disease company Ophthotech Corp. (NASDAQ:OPHT) said co-founder and CEO David Guyer will become executive chairman, effective July 1. President and CFO Glenn Sblendorio will become CEO and remain president. Ophthotech promoted SVP of Finance David Carroll to...

Read the full 175 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >